Cargando…
New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
Autores principales: | Bennardo, Francesco, Buffone, Caterina, Giudice, Amerigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270501/ https://www.ncbi.nlm.nih.gov/pubmed/32209313 http://dx.doi.org/10.1016/j.oraloncology.2020.104659 |
Ejemplares similares
-
Medication-Related Osteonecrosis of the Jaw with Spontaneous Hemimaxilla Exfoliation: Report of a Case in Metastatic Renal Cancer Patient under Multidrug Therapy
por: Bennardo, F., et al.
Publicado: (2020) -
Oral Health-Related Quality of Life and Mental Health Impairment in Patients Affected by Medication-Related Osteonecrosis of the Jaws: A Case–Control Pilot Study
por: Calabria, Elena, et al.
Publicado: (2023) -
Removal of dental implants displaced into the maxillary sinus: a retrospective single-center study
por: Bennardo, Francesco, et al.
Publicado: (2022) -
Clinical and Immunohistochemical Features of Oral Angioleiomyoma: A Comprehensive Review of the Literature and Report of a Case in a Young Patient
por: Giudice, Amerigo, et al.
Publicado: (2019) -
Tocilizumab: Another medication related to osteonecrosis of the jaws? A case report and literature review
por: Sakkas, Andreas, et al.
Publicado: (2021)